Enliven Therapeutics, Inc. (ELVN) Dividend Yield, History & Forecast
Enliven Therapeutics, Inc. (ELVN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. market capitalization is approximately $2.32B.
Frequently Asked Questions about Enliven Therapeutics, Inc. (ELVN)
Is Enliven Therapeutics, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Enliven Therapeutics, Inc. in?▾
Enliven Therapeutics, Inc. (ELVN) operates in the Healthcare sector, specifically the Biotechnology industry.
